Vaccines recommended for adolescents are underused, largely because teenage children have fewer regular wellness doctor visits, and vaccination is not often offered during sick visits. Moreover, neither parents nor healthcare providers make vaccination a priority for adolescents. Yearly preventive visits and increased reliance on schools and pharmacies as alternate delivery sites may help. Leading infectious disease experts will address the value of capturing and vaccinating the adolescent patient population to ensure disease prevention and encourage a lifelong commitment to better preventive healthcare through immunization.
Currently available vaccines are recommended to protect adolescents from more than a dozen infectious diseases, including influenza, human papillomavirus, meningococcal disease, tetanus, and hepatitis, among others. This week, the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices voted to add permissive language for human papillomavirus vaccination in boys and young men 9 to 26 (routine recommendation continues for females 9 to 26). New vaccination coverage data released last month by CDC reveal that while rates are increasing, they remain low for the vaccines specifically recommended for preteens (ages 11 and 12). Three vaccines are first recommended at age 11 - meningococcal, Tdap (which includes protection against tetanus, pertussis and diphtheria) and HPV.
CDC figures also indicate disparities in coverage according to race and poverty status:
Monday, October 26, 2009
11 a.m. Eastern Time
WHERE:
Via webcast:
https://adolescentvaccination.webex.com/adolescentvaccination/onstage/g.php?t=a&d=661328456
CONTACT: Jennifer Corrigan, 732-382-8898, 732-742-7148 (cell phone), [email protected]
Pre-registration for attendance is preferred.
/PRNewswire -- Oct. 22/
SOURCE National Foundation for Infectious Diseases
Advertisement
Currently available vaccines are recommended to protect adolescents from more than a dozen infectious diseases, including influenza, human papillomavirus, meningococcal disease, tetanus, and hepatitis, among others. This week, the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices voted to add permissive language for human papillomavirus vaccination in boys and young men 9 to 26 (routine recommendation continues for females 9 to 26). New vaccination coverage data released last month by CDC reveal that while rates are increasing, they remain low for the vaccines specifically recommended for preteens (ages 11 and 12). Three vaccines are first recommended at age 11 - meningococcal, Tdap (which includes protection against tetanus, pertussis and diphtheria) and HPV.
Advertisement
CDC figures also indicate disparities in coverage according to race and poverty status:
- Hispanic females are more likely than white females to receive the HPV vaccine
- Teens living in poverty are more likely to receive HPV vaccine than those above the poverty level
- Whites are more likely than blacks to be vaccinated against Tdap and varicella
- William Schaffner, MD, President-Elect, NFID, Program Moderator, Vanderbilt University School of Medicine
- Lance E. Rodewald, MD, Director, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC
- Amy B. Middleman, MD, Director, Adolescent and Young Adult Immunization, Texas Children's Hospital, Liaison Representative to the Advisory Committee on Immunization Practices, Society of Adolescent Medicine
- Janet Englund, MD, Associate Professor, Infectious Diseases, Department of Pediatrics, University of Washington/Seattle Children's Hospital and Regional Medical Center
Monday, October 26, 2009
11 a.m. Eastern Time
WHERE:
Via webcast:
https://adolescentvaccination.webex.com/adolescentvaccination/onstage/g.php?t=a&d=661328456
CONTACT: Jennifer Corrigan, 732-382-8898, 732-742-7148 (cell phone), [email protected]
Pre-registration for attendance is preferred.
/PRNewswire -- Oct. 22/
SOURCE National Foundation for Infectious Diseases
